See All Slides - tctmd.com

Slides

Presentation TCT 2013

Public Reporting Is Coming: Are You Ready?

Presenter: Ralph Brindis

October 31, 2013

Presentation TCT 2013

Disparities in Care of Minorities and Patients with Depressed Socio-Economic Status: Implications of the Affordable Care Act

Presenter: A.J. Conrad Smith

October 31, 2013

Presentation TCT 2013

How Would I Treat this Patient?(10)

Presenter: Vjekoslav Tomulic

October 31, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

LEVANT 2

Presenter: D. Christopher Metzger

October 31, 2013

Presentation TCT 2013

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

Presenter: Augusto Pichard

October 31, 2013

Presentation TCT 2013

Case #5: STEMI Complicated by Reperfusion Injury

Presenter: Thomas Engstr?m

October 31, 2013

Advertisement

Slides

Public Reporting Is Coming: Are You Ready?

Disparities in Care of Minorities and Patients with Depressed Socio-Economic Status: Implications of the Affordable Care Act

How Would I Treat this Patient?(10)

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

LEVANT 2

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

Case #5: STEMI Complicated by Reperfusion Injury

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content